期刊文献+

骨髓纤维化转化为急性单核细胞白血病1例并文献复习

A case report of acute monocytic leukemia transformed from myelofibrosis and a literature review
原文传递
导出
摘要 患者,男,76岁,已婚。既往有面神经麻痹病史20余年。2013年1月因“反复面色苍白、乏力3年余,加重2天”入院。患者3年余前出现面色苍白,伴乏力,伴纳差、活动后胸闷,至我院就诊,查血常规:白细胞17.8×10^9/L,血红蛋白49g/L,血小板81×10^9/L。外周血涂片:幼稚粒细胞2%,有核红细胞16%,可见泪滴型红细胞。 Summary One patient with acute monocytic leukemia(M5) transformed from myelofibrosis(MF) was reported,Karyotype analysis was 46,XY;Detecting by flow cytometry , the antigens of CD13, CD33, CDllb, CD34 and HLA-DR were found expressed. The disease progressed vary fast and the patient died of respiratory failure. Myelofibrosis has 8%%-20% of opportunity to transform to acute leukemia.
出处 《临床血液学杂志》 CAS 2015年第2期257-258,共2页 Journal of Clinical Hematology
关键词 骨髓纤维化 白血病 acute monocytic leukemia myelofibrosis
  • 相关文献

参考文献6

  • 1Silver RT,Vandris K,Goldman JJ.Recombinant inteferon-αmay retard progression of early primary myelofibrosis:apreliminary report[J].Blood,2011,117:6669-6672.
  • 2刘爱宁,钱林生,陈辉树.慢性特发性骨髓纤维化临床病理学分期与预后的关系[J].临床血液学杂志,2004,17(6):360-362. 被引量:5
  • 3Tefferi A.How I treat myelofibrosis[J].Blood,2011,117:3494-3504.
  • 4Bjrkholm M,Derolf AR,Hultcrantz M,et al.Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms[J].J Clin Oncol,2011,29:2410-2415.
  • 5Tefferi A.Classification,diagnosis and management of myeloproliferative disorders in the JAK2V617F era[J].Hematology Am Soc Hematol Educ Program,2006,36:240-245.
  • 6Stewart WA,Pearce R,Kirkland KE,et al.The role of allogeneic SCT in primary myelofibrosis:a British Society for Blood and Marrow Transplantation study[J].Bone Marrow Transplant,2010,45:1587-1593.

二级参考文献11

  • 1Thiele J, Pierre R, Lmbert M, et al. Chronic idiopathic myelofibrosis. Chronic myeloproliferative disease, unclassifiable. In: Jaffe E S, Harris N L, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, Fran
  • 2Manoharan A. Idiopathic myelofibrosis:a clinical review. Int J Hematol,1998,68:355-336.
  • 3Kvasnicka H M, Thiele J, Werden C, et al. Prognostic factors in ldiopathic(primary) osteomyelofibrosis. Cancer,1997,80:708-718.
  • 4Schmitt A, Drouin A, Masse J M, et al. Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis. Leukemia and Lymphoma,2002,43:719-724.
  • 5Thiele J, Kvasinicka H M, Zankocich R, et al. Early-stage idiopathic (primary) myelofibrosis-current issues of diagnostic features. Leukemia and Lymphoma,2002,43:1035-1041.
  • 6Thiele J, Kvasinicka H M, Zankocich R, et al. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Ann Hematol,2001,80:160-165.
  • 7Thiele J, Kvasnicka H M.Chronic myeloproliferative disorders with thrombocythemia:a comparative study of two classification systems (PVSG,WHO) on 839 patients. Ann Hematol, 2003,82:148-152.
  • 8Thiele J, Kvasnicka H M, Boeltken B, et al. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF)- a clinicopathological study.Leukemia,1999,13:1741-1748.
  • 9Buhr T, Langer F, Kreft A, et al. The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients. Pathologe,2002,23:433-437.
  • 10Thiele J, Kvasinicka H M, Schmitt-Graeff A, et al. Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy:a follow-up study on 309 patients. Leukemia and Lymphoma,2003,44:949-953.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部